GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestra Inc (XKRX:352770) » Definitions » YoY EPS Growth

Celestra (XKRX:352770) YoY EPS Growth : -256.15% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Celestra YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Celestra's YoY EPS Growth for the quarter that ended in Mar. 2025 was -256.15%.

Celestra's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ₩-3,951.27.

Celestra YoY EPS Growth Historical Data

The historical data trend for Celestra's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestra YoY EPS Growth Chart

Celestra Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial -92.77 175.98 -143.30 -570.38 20.43

Celestra Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.60 69.78 17.90 -19.80 -256.15

Celestra YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Celestra's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-18800.6--23628.186)/ | -23628.186 |
=20.43 %

Celestra's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(-3951.269--1109.445)/ | -1109.445 |
=-256.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celestra YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Celestra's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Celestra Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestra Inc (XKRX:352770) » Definitions » YoY EPS Growth
Comparable Companies
XKRX:341170 XKRX:066830 XKRX:244460 XKRX:188260 XKRX:266470 XKRX:251280 XKRX:299480 XKRX:179530 XKRX:322970 XKRX:065650 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Building 110, UNIST, 50, Suite 301-3, UNIST-gil, Eonyang-eup, Ulju-gun, Ulsan, KOR, 44919
Website
http://www.clinomics.com
Celestra Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology. It offers a genome-based, early cancer diagnostic service through technology for multi-omics analysis and simultaneous detection of CTC and cfDNA in the blood based.

Celestra Headlines

No Headlines